Vanta Bioscience Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
Y/e 31 Mar | Mar-2020 | - | - | - |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -- | -- | -- | -- |
Op profit growth | -- | -- | -- | -- |
EBIT growth | -- | -- | -- | -- |
Net profit growth | -- | -- | -- | -- |
Profitability ratios (%) | ||||
OPM | 30.90 | -- | -- | -- |
EBIT margin | 23.30 | -- | -- | -- |
Net profit margin | 7.22 | -- | -- | -- |
RoCE | -- | -- | -- | -- |
RoNW | -- | -- | -- | -- |
RoA | -- | -- | -- | -- |
Per share ratios () | ||||
EPS | 1.60 | -- | -- | -- |
Dividend per share | -- | -- | -- | -- |
Cash EPS | (0.30) | -- | -- | -- |
Book value per share | 37.20 | -- | -- | -- |
Valuation ratios | ||||
P/E | 56.90 | -- | -- | -- |
P/CEPS | (343) | -- | -- | -- |
P/B | 2.45 | -- | -- | -- |
EV/EBIDTA | 16.70 | -- | -- | -- |
Payout (%) | ||||
Dividend payout | -- | -- | -- | -- |
Tax payout | (25) | -- | -- | -- |
Liquidity ratios | ||||
Debtor days | -- | -- | -- | -- |
Inventory days | -- | -- | -- | -- |
Creditor days | -- | -- | -- | -- |
Leverage ratios | ||||
Interest coverage | (1.70) | -- | -- | -- |
Net debt / equity | 0.73 | -- | -- | -- |
Net debt / op. profit | 3.93 | -- | -- | -- |
Cost breakup () | ||||
Material costs | (8.30) | -- | -- | -- |
Employee costs | (36) | -- | -- | -- |
Other costs | (25) | -- | -- | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
Y/e 31 Mar( In .Cr) | Mar-2020 | - | - | - |
---|---|---|---|---|
Revenue | 14.10 | -- | -- | -- |
yoy growth (%) | -- | -- | -- | -- |
Raw materials | (1.20) | -- | -- | -- |
As % of sales | 8.34 | -- | -- | -- |
Employee costs | (5.10) | -- | -- | -- |
As % of sales | 35.90 | -- | -- | -- |
Other costs | (3.50) | -- | -- | -- |
As % of sales | 24.90 | -- | -- | -- |
Operating profit | 4.37 | -- | -- | -- |
OPM | 30.90 | -- | -- | -- |
Depreciation | (1.20) | -- | -- | -- |
Interest expense | (1.90) | -- | -- | -- |
Other income | 0.11 | -- | -- | -- |
Profit before tax | 1.34 | -- | -- | -- |
Taxes | (0.30) | -- | -- | -- |
Tax rate | (25) | -- | -- | -- |
Minorities and other | 0.01 | -- | -- | -- |
Adj. profit | 1.02 | -- | -- | -- |
Exceptional items | -- | -- | -- | -- |
Net profit | 1.02 | -- | -- | -- |
yoy growth (%) | -- | -- | -- | -- |
NPM | 7.22 | -- | -- | -- |
- Switch to
-
Tabular DataGraph
Y/e 31 Mar ( In .Cr) | Mar-2020 | - | - | - |
---|---|---|---|---|
Profit before tax | 1.34 | -- | -- | -- |
Depreciation | (1.20) | -- | -- | -- |
Tax paid | (0.30) | -- | -- | -- |
Working capital | -- | -- | -- | -- |
Other operating items | -- | -- | -- | -- |
Operating cashflow | -- | -- | -- | -- |
Capital expenditure | -- | -- | -- | -- |
Free cash flow | -- | -- | -- | -- |
Equity raised | -- | -- | -- | -- |
Investments | -- | -- | -- | -- |
Debt financing/disposal | -- | -- | -- | -- |
Dividends paid | -- | -- | -- | -- |
Other items | -- | -- | -- | -- |
Net in cash | -- | -- | -- | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2019 | - | - |
---|---|---|---|---|
Equity capital | 6.31 | 6.31 | -- | -- |
Preference capital | -- | -- | -- | -- |
Reserves | 17.20 | 15.90 | -- | -- |
Net worth | 23.50 | 22.30 | -- | -- |
Minority interest | ||||
Debt | 17.40 | 13.30 | -- | -- |
Deferred tax liabilities (net) | 0.59 | 0.40 | -- | -- |
Total liabilities | 42.40 | 36.90 | -- | -- |
Fixed assets | 27.80 | 21.60 | -- | -- |
Intangible assets | ||||
Investments | -- | 1.95 | -- | -- |
Deferred tax asset (net) | -- | -- | -- | -- |
Net working capital | 14.50 | 10.10 | -- | -- |
Inventories | 14 | 9.24 | -- | -- |
Inventory Days | 362 | -- | -- | -- |
Sundry debtors | 1.39 | 1.56 | -- | -- |
Debtor days | 35.90 | -- | -- | -- |
Other current assets | 5.22 | 1.38 | -- | -- |
Sundry creditors | (3.20) | (0.50) | -- | -- |
Creditor days | 81.60 | -- | -- | -- |
Other current liabilities | (3) | (1.60) | -- | -- |
Cash | 0.20 | 3.27 | -- | -- |
Total assets | 42.40 | 36.90 | -- | -- |
- Switch to
-
ConsolidatedStandalone
Particulars ( Rupees In Crores.) | Mar-2020 | Mar-2019 | Mar-2018 | - | - |
---|---|---|---|---|---|
Gross Sales | 14.10 | 12.50 | 3.99 | -- | -- |
Excise Duty | -- | -- | -- | -- | -- |
Net Sales | 14.10 | 12.50 | 3.99 | -- | -- |
Other Operating Income | -- | -- | -- | -- | -- |
Other Income | 0.11 | 0.23 | 0.05 | -- | -- |
Total Income | 14.30 | 12.70 | 4.04 | -- | -- |
Total Expenditure ** | 9.77 | 9.21 | 2.96 | -- | -- |
PBIDT | 4.48 | 3.50 | 1.08 | -- | -- |
Interest | 1.95 | 1.69 | 0.20 | -- | -- |
PBDT | 2.53 | 1.81 | 0.89 | -- | -- |
Depreciation | 1.19 | 0.71 | 0.57 | -- | -- |
Minority Interest Before NP | -- | -- | -- | -- | -- |
Tax | 0.15 | 0.23 | 0.06 | -- | -- |
Deferred Tax | 0.19 | 0.17 | 0.23 | -- | -- |
Reported Profit After Tax | 1 | 0.70 | 0.03 | -- | -- |
Minority Interest After NP | -- | -- | -- | -- | -- |
Net Profit after Minority Interest | 1 | 0.70 | 0.03 | -- | -- |
Extra-ordinary Items | -- | -- | -- | -- | -- |
Adjusted Profit After Extra-ordinary item | 1 | 0.70 | 0.03 | -- | -- |
EPS (Unit Curr.) | 1.59 | 1.19 | 0.05 | -- | -- |
Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
Dividend (%) | -- | -- | -- | -- | -- |
Equity | 6.31 | 6.31 | 5.73 | -- | -- |
Public Shareholding (Number) | -- | -- | -- | -- | -- |
Public Shareholding (%) | -- | -- | -- | -- | -- |
Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
PBIDTM(%) | 31.70 | 28 | 27.10 | -- | -- |
PBDTM(%) | 17.90 | 14.50 | 22.30 | -- | -- |
PATM(%) | 7.07 | 5.61 | 0.75 | -- | -- |